Clinical Trials Browser

Endometrial Neoplasms × Tyrosine Kinase Inhibitors × 90 days × Clear all

NCT05824481 2026-03-10

Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer

Phase 2 Active not recruiting

Endometrial Neoplasms